- $334.81m
- $774.20m
- $93.62m
- 49
- 56
- 77
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27.8 | 28.1 | 32.1 | 70.5 | 93.6 |
Cost of Revenue | |||||
Gross Profit | 15.4 | 15.7 | 17.9 | 40 | 51.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 37.5 | 41.6 | 43.7 | 86 | 107 |
Operating Profit | -9.76 | -13.5 | -11.6 | -15.5 | -13.6 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1.96 | -19.5 | 29.5 | 50.9 | 4.07 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.69 | -19.7 | 29.3 | 50.1 | 4.01 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.856 | -19.9 | 29.1 | 50 | 3.87 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.856 | -19.9 | 29.1 | 50 | 3.87 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.318 | -1.02 | 1.38 | 2.83 | 0.144 |
Dividends per Share |